HanchorBio Inc. (TPEX:7827)
Taiwan · Delayed Price · Currency is TWD 138.50
-0.50 (-0.36%)
At close: May 7, 2026
HanchorBio Market Cap
HanchorBio has a market cap or net worth of 17.55 billion as of May 8, 2026.
Market Cap
17.55B
Enterprise Value
16.74B
Revenue
312.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
138.50
Market Cap Chart
Since June 20, 2025, HanchorBio's market cap has increased from 5.52B to 17.55B, an increase of 217.95%. That is a compound annual growth rate of 271.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 17.55B | 52.37% |
| Dec 31, 2025 | 11.52B | 108.67% |
| Jun 20, 2025 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elixiron Immunotherapeutics (Cayman) Limited | 9.44B |
| Uwell Biopharma | 8.32B |
| Intelligene | 7.54B |
| Obigen Pharma | 4.16B |
| BIONET Therapeutics | 2.84B |
| Pet Pharm Biotech | 2.73B |
| FullHope Biomedical | 1.10B |
| Han.biomedical | 683.57M |